Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Oleo Sci ; 67(12): 1551-1562, 2018 Dec 01.
Article in English | MEDLINE | ID: mdl-30429440

ABSTRACT

The aim of the present research was to Study the prevention of dyslipidemia, oxidative stress, inflammation and fatty liver as risk factors for cardiovascular disease via intervention by borage oil (B) and fish oil (F) with or without turmeric (T) and alpha-tocopherols (TC). Fatty acids were assessed in both oils while curcuminoids were determined in turmeric. Rats were divided into; first group fed on balanced diet and designated as normal control (NC), second fed on dyslipidemic and steatohepatitis (DS) inducer diet which represented the DS control group and groups 3-6 fed on DS inducer diet with daily oral administration of B, B+T+TC, F and F+T+TC; respectively for 5 weeks. Liver fat and plasma lipid profile, oxidative stress and inflammatory biomarker and liver and heart histopathology were assessed. Results showed gamma linolenic to be 21.01% in B. F contained eicosapentaenoic as 22.768% and docosahexaenoic acid as 13.574%.Total curcuminoids were 4.63 mg/g turmeric. The DS control group showed significant dyslipidemia, elevated malondialdehyde (MDA), tumor necrosis factor-alpha and liver fat with significant reduction in total antioxidant capacity (TAC) compared to NC. The different treatments produced significant improvement in all the parameters and histopathology. F was superior to B in ameliorating liver histopathological changes while B was more efficient in elevating TAC. B was more promising in improving lipid profile and liver fat compared to B + T + TC, while the latter was superior in improving MDA and liver histopathology. Fish oil was more efficient than F+TC+T except for TAC and high density lipoprotein cholesterol which were more improved on addition of TC and T. Conclusion: Borage and fish oil with or without antioxidants protect from cardiovascular and fatty liver diseases with variable degrees.


Subject(s)
Cardiovascular Diseases/drug therapy , Dietary Supplements , Fatty Liver/drug therapy , Fish Oils/therapeutic use , Plant Oils/therapeutic use , alpha-Tocopherol/therapeutic use , Animals , Antioxidants/chemistry , Antioxidants/therapeutic use , Borago/chemistry , Cardiovascular Diseases/pathology , Curcuma/chemistry , Curcumin/chemistry , Curcumin/therapeutic use , Dyslipidemias/drug therapy , Dyslipidemias/pathology , Fatty Acids, Unsaturated/chemistry , Fatty Acids, Unsaturated/therapeutic use , Fatty Liver/pathology , Fish Oils/chemistry , Liver/pathology , Male , Metabolic Syndrome/drug therapy , Metabolic Syndrome/pathology , Myocardium/pathology , Plant Oils/chemistry , Rats, Sprague-Dawley , Seeds/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...